Cabozantinib: A Multi ‐targeted Oral Tyrosine Kinase Inhibitor
This article is protected by copyright. All rights reserved.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: Jordan N. Markowitz, Karen M. Fancher Tags: Review of Therapeutics Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Drugs & Pharmacology | Food and Drug Administration (FDA) | Hepatocellular Carcinoma | Jordan Health | Kidney Cancer | Liver Cancer | Lung Cancer | Middle East Health | Oral Cancer | Prostate Cancer | Renal Cell Carcinoma | Study | Thyroid | Thyroid Cancer | USA Health